Cancer and blood coagulation

Cellular and Molecular Life Sciences

Volumn 63, Issue 9, 2006, Pages 1024-1027

  Boccaccio, C ^a   Medico, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Blood coagulation; Cancer; COX 2; Fibrin; Haemostasis; Invasive growth; MET; Oncogene; PAI 1

Indexed keywords

FIBRIN;

BLOOD CLOTTING DISORDER; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; HUMAN; ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOOD COAGULATION; CYCLOOXYGENASE 2; FIBRIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMOSTASIS; HUMANS; MEMBRANE PROTEINS; MODELS, GENETIC; NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 33744465240     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5570-9     Document Type: Review

References (28)

1. Rickles F. R. and Levine M. N. (2001) Epidemiology of thrombosis in cancer. Acta haematol. 106: 6-12
2. Trousseau A. (1865) Phlegmasia alba dolens. In: Clinique Médicale de l'Hotel-Dieu de Paris, vol. 3. pp. 654-712, JB Ballière et Fils, Paris
3. Baron J. A., Gridley G., Weiderpass E., Nyrén O. and Linet M. (1998) Venous thromboembolism and cancer. Lancet 351: 1077-1080
4. Billroth T. (1878) Lectures on Surgical Pathology and Therapeutics: A Handbook for Students and Practictioners, 8 edn., New Sydenham Society, London
5. De Cicco M. (2004) The prothrombotic state in cancer: pathogenic mechanisms. Crit. Rev. Oncol. Hematol. 50: 187-196
6. Levine M. N., Lee A. Y. and Kakkar, A. K. (2003) From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. J. Thromb. Haemost. 1: 1456-1463
7. Mann K. G. (1999) Biochemistry and physiology of blood coagulation. Thromb. Haemost. 82: 165-174
8. Dvorak H. F. (1986) Tumors: wounds that do not heal. NEJM 315: 1650-1659
9. Yu J. L. and Rak J. W. (2004) Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J. Thromb. Haemost. 2: 2065-2067
10. Yu J. L., May L., Lhotak V., Shahrzad S., Shirasawa S., Weitz J. I. et al. (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105: 1734-1741
11. Rong Y., Post D. E., Pieper R. O., Durden D. L., Van Meir E. G. and Brat D. J. (2005) PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res. 65: 1406-1413
12. Boccaccio C., Sabatino G., Medico E., Girolami F., Follenzi A., Reato G. et al. (2005) The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 434: 396-400
13. Trusolino L. and Comoglio P. M. (2002) Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. Cancer 4: 289-300
14. Durand M. K., Bodker J. S., Christensen A., Dupont D. M., Hansen M., Jensen J. K. et al. (2004) Plasminogen activator inhibitor-I and tumour growth, invasion and metastasis. Thromb. Haemost. 91: 438-449
15. Kohler H. P. and Grant P. J. (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. NEJM 342: 1792-1801
16. Smith W. L., De Witt D. L. and Garavito R. M. (2000) Cyclooxygenases: structural, cellular and Molecular Biology. Annu. Rev. Biochem. 69: 145-182
17. FitzGerald G. A. (2003) COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat. Rev. Drug Discov. 2: 879-890
18. Look M. P., van Putten W. L., Duffy M. J., Harbeck N., Christensen I. J., Thomssen C. et al. (2002) Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J. Natl. Cancer Inst. 94: 116-128
19. Dvorak H. F. (2003) Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am. J. Pathol. 162: 1747-1757
20. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I. et al. (1996) Nature 383: 73-75
21. Rickles F. R., Shoji M. and Abe K. (2001) The role of the hemostatic system in tumor growth, metastasis and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int. J. Hematol. 73: 145-150
22. Carmeliet P. (2001) Biomedicine. Clotting factors build blood vessels. Science 293: 1602-1604
23. Nash G. F., Walsh D. C. and Kakkar A. K. (2001) The role of the coagulation system in tumour angiogenesis. Lancet Oncol. 2: 608-613, 2001
24. Hu L., Lee M., Campbell W., Perez-Soler R. and Karpatkin S. (2004) Role of endogenous thrombin in tumor implantation, seeding and spontaneous metastasis. Blood 104: 2746-2751
25. Im J. H., Fu W., Wang H., Bhatia S. K., Hammer D. A., Kowalska M. A. et al. (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 64: 8613-8619
26. Caunt M., Huang Y. Q., Brooks P. C. and Karpatkin S. Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J. Thromb. Haemost. 1: 2097-2102
27. Kakkar A. K. and Levine M. N. (2004) Thrombosis and cancer: implications beyond Trousseau. J. Thromb. Haemost. 2: 1261-1262
28. Petralia G. A., Lemoine N. R. and Kakkar A. K. (2005) Mechanisms of disease: the impact of antithrombotic therapy in cancer patients. Nat. Clin. Pract. Oncol. 2: 356-363